US6793451088 - OKYO (XNAS)
OKYO Pharma Limited - Ordinary Shares Aktie
1,09 USD
Aktuelle Kurse von OKYO Pharma Limited - Ordinary Shares
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
OKYO
|
USD
|
21.12.2024 00:51
|
1,09 USD
| 1,08 USD | 0,93 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | 4,80 % | 3,81 % | 11,21 % | -12,80 % | -38,76 % | -69,89 % |
Company Profile for OKYO Pharma Limited - Ordinary Shares Share
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Company Data for OKYO Pharma Limited - Ordinary Shares Share
Name OKYO Pharma Limited - Ordinary Shares
Company OKYO Pharma Limited
Symbol OKYO
Website https://www.okyopharma.com
Primary Exchange
NASDAQ
ISIN US6793451088
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Gary S. Jacob Ph.D.
Market Capitalization 41 Mio
Country United Kingdom
Currency USD
Employees 0,0 T
Address 55 Park Lane, W1K 1NA London
IPO Date 2022-05-17
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | OKYO |
More Shares
Investors who OKYO Pharma Limited - Ordinary Shares hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.